A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week. The diagnostic tool, the Elecsys pTau 181 plasma test, is developed by ...

85% said they were willing to complete a test if their clinician recommended it ...

Capillary blood tests measure p-tau217, GFAP, and NfL without strict temperature controls or immediate centrifugation. Primary care physicians currently have a diagnostic accuracy of ~61% for ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

In 2021, 57 million people across the planet were living with dementia. This class of memory-related diseases is the world’s seventh greatest killer, and Alzheimer’s disease is its most common form.

Last month, The US Food and Drug Administration approved a new blood test for assisting the diagnosis of Alzheimer’s disease. Produced by Roche, Elecsys pTau181 measures the concentration of a ...

Alzheimer's can be detected early with p-tau blood biomarkers, but some tests can lead to overdiagnosis. Combining p-tau217 and eMTBR-tau243 may refine diagnostic accuracy and reduce false-positives.

A protein lurking around in the blood can help with the accurate diagnosis of Alzheimer's disease. In a recent study, researchers from Spain investigated how blood-based biomarkers, such as a protein ...

The tests could help to improve dementia care, but scientists say there are still some caveats and unknowns. By Dana G. Smith Could a simple blood test predict your risk of getting dementia years, or ...

Scientists are turning to AI and speech analysis to uncover early signs of Alzheimer’s in ways traditional methods may miss.